Physician profile
Florence Schaefer
$1,547.75
in general payments reported to CMS, 2019-2025
13 companies · $556 in 2025
The $556 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $209 · 2023: $431 · 2024: $353 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $226.56 | 2023-2024 | Inspire |
| Genzyme Corporation | $218.31 | 2023-2024 | |
| Gilead Sciences, INC. | $215.40 | 2025 | Livdelzi, Epclusa |
| Abbott Laboratories | $136.58 | 2025 | Proclaim |
| Csl Behring | $124.64 | 2024 | Hizentra |
| Astrazeneca Pharmaceuticals Lp | $121.86 | 2025 | Saphnelo |
| Novo Nordisk INC | $97.20 | 2023 | |
| Abbvie INC. | $90.55 | 2022 | |
| Edwards Lifesciences Corporation | $89.89 | 2022 | |
| Abiomed | $82.00 | 2025 | |
| Biogen, INC. | $76.29 | 2023 | |
| Pfizer INC. | $40.27 | 2023 | |
| Nevro Corp. | $28.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.